4//SEC Filing
KLEIN JOSEPH III 4
Accession 0000874015-24-000163
CIK 0000874015other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 2:47 PM ET
Size
9.1 KB
Accession
0000874015-24-000163
Insider Transaction Report
Form 4
KLEIN JOSEPH III
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-07-01+10,111→ 10,111 totalExercise: $47.11From: 2025-07-01Exp: 2034-06-30→ Common Stock (10,111 underlying) - Award
Restricted Stock Unit
2024-07-01+4,079→ 8,756 totalExercise: $0.00→ Common Stock (4,079 underlying)
Footnotes (4)
- [F1]Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2024 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718.
- [F2]Grant on July 1, 2024 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2024.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F4]Grant of Restricted Stock Unit award on July 1, 2024 to the reporting person under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier; however, the reporting person has elected to defer delivery of such shares until the earlier to occur of the 30th day following the reporting person's Separation from Service from the Company or the date of a Change in Control of the Company, both as defined in Treasury Regulation Section 1.409A. These Restricted Stock Units are vested as to 0 shares on July 1, 2024
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001206369
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 2:47 PM ET
- Size
- 9.1 KB